Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1725]

WCLC 2022: Consolidation nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiation for patients with unresectable stage III NSCLC

WCLC 2022: Consolidation nivolumab and ipilimumab or nivolumab alone following concurrent chemoradiation for...

WCLC 2022: Sugemalimab a safe and effective consolidation therapy for unresectable stage III NSCLC

WCLC 2022: Sugemalimab a safe and effective consolidation therapy for unresectable stage III NSCLC

Regular screening of people at high risk for pancreatic cancer pays off

Regular screening of people at high risk for pancreatic cancer pays off

Children in low-income countries 16 times more likely to die from most common eye cancer

Children in low-income countries 16 times more likely to die from most common eye cancer

A machine learning model to predict immunotherapy response in cancer patients

A machine learning model to predict immunotherapy response in cancer patients

Lung cancer: When radiotherapy fails

Lung cancer: When radiotherapy fails

Positive outcome of the phase III trial: combination of PCV chemotherapy and RT in patients with anaplastic oligodendroglial tumours

Positive outcome of the phase III trial: combination of PCV chemotherapy and RT in patients with anaplastic...

The effect of breast cancer screening is declining

The effect of breast cancer screening is declining

Contrast-enhanced mammography vs MRI: Neoadjuvant therapy response in breast cancer

Contrast-enhanced mammography vs MRI: Neoadjuvant therapy response in breast cancer

Scientists blend AI, 3D tissue imaging to identify aggressive prostate cancer

Scientists blend AI, 3D tissue imaging to identify aggressive prostate cancer

More from ecancer